Gold-doxorubicin nanoconjugates for overcoming multidrug resistance

Nanomedicine. 2012 Feb;8(2):204-11. doi: 10.1016/j.nano.2011.06.005. Epub 2011 Jun 24.

Abstract

Multidrug resistance (MDR) is a major clinical obstacle to the success of cancer chemotherapy. Here we developed a gold-doxorubicin (DOX) nanoconjugates system to overcome MDR. Gold nanoparticles (AuNPs) were first PEGylated as Au-PEG-NH(2), and DOX was then grafted onto AuNPs via a cleavable disulfide linkage (Au-PEG-SS-DOX). Confocal images revealed that the extent of intracellular uptake of Au-PEG-SS-DOX was greater than that of free DOX in the MDR cells, and inductively coupled plasma mass spectroscopy analysis further confirmed that AuNPs significantly increased the level of drug accumulation in MDR cells at a nanoparticles dose greater than 15 μM. The cytotoxicity study demonstrated that the Au-PEG-SS-DOX nanoconjugates system efficiently released the anticancer drug DOX and enhanced its cytotoxicity against MDR cancer cells. This study highlights the potential of using AuNPs for overcoming of MDR in cancer chemotherapy.

From the clinical editor: This study demonstrates that gold nanoparticles can be successfully applied to overcome MDR in cancer chemotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Doxorubicin / chemistry
  • Doxorubicin / pharmacology*
  • Drug Carriers / adverse effects
  • Drug Carriers / chemistry*
  • Drug Resistance, Multiple / drug effects*
  • Gold / adverse effects
  • Gold / chemistry*
  • Hep G2 Cells
  • Humans
  • Metal Nanoparticles / adverse effects
  • Metal Nanoparticles / chemistry*
  • Microscopy, Confocal
  • Molecular Structure
  • Polyethylene Glycols / chemistry

Substances

  • Drug Carriers
  • Polyethylene Glycols
  • Gold
  • Doxorubicin